2',3'-Didehydro-2',3'-dideoxyuridine
2',3'-Didehydro-2',3'-dideoxyuridine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
Product Specifications
CAS Number
5974-93-6
UNSPSC
12352005
Hazard Statement
H315-H319-H335
Target
Nucleoside Antimetabolite/Analog
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/2-3-didehydro-2-3-dideoxyuridine.html
Solubility
10 mM in DMSO
Smiles
OC[C@@H]1C=C[C@H](N2C(NC(C=C2)=O)=O)O1
Molecular Formula
C9H10N2O4
Molecular Weight
210.19
Precautions
P261-P264-P271-P280-P302+P352-P304+P340-P362+P364-P405-P501
References & Citations
[1]Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18 (23) :3373-88.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Calponin-1 (CALP + CNN1/832), CF740 conjugate, 0.1mg/mL
Glycophorin A / CD235a (Erythrocyte Marker) (N/A), CF594 conjugate, 0.1mg/mL
CD21 (Mature B-Cell & Follicular Dendritic Cell Marker) (rCR2/1952), CF647 conjugate, 0.1mg/mL
Cytokeratin, pan (AE-1 / AE-3), CF640R conjugate, 0.1mg/mL
